185 related articles for article (PubMed ID: 23089699)
1. DNA methylation biomarkers and their utility for solid cancer diagnostics.
Heichman KA; Warren JD
Clin Chem Lab Med; 2012 Oct; 50(10):1707-21. PubMed ID: 23089699
[TBL] [Abstract][Full Text] [Related]
2. Analysis of DNA Methylation Status in Bodily Fluids for Early Detection of Cancer.
Yokoi K; Yamashita K; Watanabe M
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28358330
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic epigenetic biomarkers in cancer.
Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation based biomarkers in colorectal cancer: A systematic review.
Lam K; Pan K; Linnekamp JF; Medema JP; Kandimalla R
Biochim Biophys Acta; 2016 Aug; 1866(1):106-20. PubMed ID: 27385266
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of channel-related genes in cancers.
Ouadid-Ahidouch H; Rodat-Despoix L; Matifat F; Morin G; Ahidouch A
Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2621-8. PubMed ID: 25703813
[TBL] [Abstract][Full Text] [Related]
6. Epigenomic biomarkers for prognostication and diagnosis of gastrointestinal cancers.
Wong CC; Li W; Chan B; Yu J
Semin Cancer Biol; 2019 Apr; 55():90-105. PubMed ID: 29665409
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation and cancer diagnosis: new methods and applications.
Dehan P; Kustermans G; Guenin S; Horion J; Boniver J; Delvenne P
Expert Rev Mol Diagn; 2009 Oct; 9(7):651-7. PubMed ID: 19817550
[TBL] [Abstract][Full Text] [Related]
8. The Role of Epigenomics in the Study of Cancer Biomarkers and in the Development of Diagnostic Tools.
Verma M
Adv Exp Med Biol; 2015; 867():59-80. PubMed ID: 26530360
[TBL] [Abstract][Full Text] [Related]
9. Significance of aberrant DNA methylation for cancer diagnostics and therapy.
Urban T; Pokorná P; Slabý O
Klin Onkol; 2024; 38(2):88-94. PubMed ID: 38697816
[TBL] [Abstract][Full Text] [Related]
10. Utility of DNA methylation markers for diagnosing cancer.
Qureshi SA; Bashir MU; Yaqinuddin A
Int J Surg; 2010; 8(3):194-8. PubMed ID: 20139036
[TBL] [Abstract][Full Text] [Related]
11. A two-gene blood test for methylated DNA sensitive for colorectal cancer.
Pedersen SK; Baker RT; McEvoy A; Murray DH; Thomas M; Molloy PL; Mitchell S; Lockett T; Young GP; LaPointe LC
PLoS One; 2015; 10(4):e0125041. PubMed ID: 25928810
[TBL] [Abstract][Full Text] [Related]
12. Identification of diagnostic markers in colorectal cancer via integrative epigenomics and genomics data.
Kok-Sin T; Mokhtar NM; Ali Hassan NZ; Sagap I; Mohamed Rose I; Harun R; Jamal R
Oncol Rep; 2015 Jul; 34(1):22-32. PubMed ID: 25997610
[TBL] [Abstract][Full Text] [Related]
13. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide screening for understanding the role of DNA methylation in colorectal cancer.
Sipos F; Mũzes G; Patai AV; Fũri I; Péterfia B; Hollósi P; Molnár B; Tulassay Z
Epigenomics; 2013; 5(5):569-81. PubMed ID: 24059802
[TBL] [Abstract][Full Text] [Related]
15. The potential of DNA modifications as biomarkers and therapeutic targets in oncology.
Jankowska AM; Millward CL; Caldwell CW
Expert Rev Mol Diagn; 2015; 15(10):1325-37. PubMed ID: 26394702
[TBL] [Abstract][Full Text] [Related]
16. The epigenetic promise for prostate cancer diagnosis.
Van Neste L; Herman JG; Otto G; Bigley JW; Epstein JI; Van Criekinge W
Prostate; 2012 Aug; 72(11):1248-61. PubMed ID: 22161815
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide hypomethylation and specific tumor-related gene hypermethylation are associated with esophageal squamous cell carcinoma outcome.
Hoshimoto S; Takeuchi H; Ono S; Sim MS; Huynh JL; Huang SK; Marzese DM; Kitagawa Y; Hoon DS
J Thorac Oncol; 2015 Mar; 10(3):509-17. PubMed ID: 25514805
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients.
Fleischer T; Edvardsen H; Solvang HK; Daviaud C; Naume B; Børresen-Dale AL; Kristensen VN; Tost J
Int J Cancer; 2014 Jun; 134(11):2615-25. PubMed ID: 24395279
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modifications and human pathologies: cancer and CVD.
Duthie SJ
Proc Nutr Soc; 2011 Feb; 70(1):47-56. PubMed ID: 21067630
[TBL] [Abstract][Full Text] [Related]
20. A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis.
Ashour N; Angulo JC; Andrés G; Alelú R; González-Corpas A; Toledo MV; Rodríguez-Barbero JM; López JI; Sánchez-Chapado M; Ropero S
Prostate; 2014 Sep; 74(12):1171-82. PubMed ID: 24961912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
